IS IRON OVERLOAD ASSOCIATED WITH WORSE OUTCOMES IN PATIENTS WITH CHRONIC LIVER DISEASE UNDERGOING LIVER TRANSPLANTATION?

被引:0
|
作者
Rodriguez-rodriguez, Sergio [1 ]
Olivas-martinez, Antonio [2 ]
la Mora, Jesus delgado-de
Martinez-benitez, Braulio [3 ]
Garcia-juarez, Ignacio [4 ]
Demichelis-gomez, Roberta [1 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran INC, Dept Hematol & Oncol, Mexico City, Mexico
[2] Univ Washington, Dept Biostat, Seattle, WA USA
[3] INCMNSZ, Dept Pathol, Mexico City, Mexico
[4] INCMNSZ, Dept Gastroenterol, Mexico City, Mexico
关键词
Ferritin; Iron overload; Liver transplantation; Post-transplant complications; Outcome measurement; HEPATIC IRON; HEREDITARY HEMOCHROMATOSIS; GENETIC HEMOCHROMATOSIS; INFECTION; PATHOLOGY; CIRRHOSIS; SURVIVAL; MEXICO;
D O I
10.24875/RIC.23000246
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Iron overload is frequent in patients with chronic liver disease, associated with shorter survival after liver transplantation in patients with hereditary hemochromatosis. Its effect on patients without hereditary hemochromatosis is unclear. The aim of the study was to study the clinical impact of iron overload in patients who underwent liver transplantation at an academic tertiary referral center. Methods: We performed a retrospective cohort study including all patients without hereditary hemochromatosis who underwent liver transplantation from 2015 to 2017 at an academic tertiary referral center in Mexico City. Explant liver biopsies were reprocessed to obtain the histochemical hepatic iron index, considering a score >- 0.15 as iron overload. Baseline characteristics were compared between patients with and without iron overload. Survival was estimated using the Kaplan-Meier method, compared with the log-rank test and the Cox proportional hazards model. Results: Of 105 patients included, 45% had iron overload. Viral and metabolic etiologies, alcohol consumption, and obesity were more frequent in patients with iron overload than in those without iron overload (43% vs. 21%, 32% vs. 22%, p = 0.011; 34% vs. 9%, p = 0.001; and 32% vs. 12%, p = 0.013, respectively). Eight patients died within 90 days after liver transplantation (one with iron overload). Complication rate was higher in patients with iron overload versus those without iron overload (223 vs. 93 events/100 personmonths; median time to any complication of 2 vs. 3 days, p = 0.043), without differences in complication type. Fatality rate was lower in patients with iron overload versus those without iron overload (0.7 vs. 4.5 deaths/100 person-months, p = 0.055). Conclusion: Detecting iron overload might identify patients at risk of early complications after liver transplantation. Further studies are required to understand the role of iron overload in survival.
引用
收藏
页码:18 / 28
页数:68
相关论文
共 50 条
  • [21] Outcomes in patients with Hepatopulmonary syndrome undergoing liver transplantation
    Kim, HY
    Choi, MS
    Lee, SC
    Park, SW
    Lee, JH
    Koh, KC
    Paik, SW
    Yoo, BC
    Rhee, JC
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (09) : 2762 - 2763
  • [22] The Outcomes of Liver Transplantation in Severe Metabolic Dysfunction-Associated Steatotic Liver Disease Patients
    Paklar, Natasa
    Mijic, Maja
    Filipec-Kanizaj, Tajana
    BIOMEDICINES, 2023, 11 (11)
  • [23] Cardiac Iron Overload Following Liver Transplantation in Patients without Hemochromatosis
    Papadodima, Stavroula
    Masia, Ricard
    Stone, James R.
    LABORATORY INVESTIGATION, 2017, 97 : 84A - 84A
  • [24] Nutrition Support and Infections Associated With Hepatic Resection and Liver Transplantation in Patients With Chronic Liver Disease
    Masuda, Toshiro
    Shirabe, Ken
    Yoshiya, Shohei
    Matono, Rumi
    Morita, Kazutoyo
    Hashimoto, Naotaka
    Ikegami, Toru
    Yoshizumi, Tomoharu
    Baba, Hideo
    Maehara, Yoshihiko
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2013, 37 (03) : 318 - 326
  • [25] The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease
    Irvine, Katharine M.
    Wockner, Leesa F.
    Shanker, Mihir
    Fagan, Kevin J.
    Horsfall, Leigh U.
    Fletcher, Linda M.
    Ungerer, Jacobus P. J.
    Pretorius, Carel J.
    Miller, Gregory C.
    Clouston, Andrew D.
    Lampe, Guy
    Powell, Elizabeth E.
    LIVER INTERNATIONAL, 2016, 36 (03) : 370 - 377
  • [26] Cardiac Iron Overload Following Liver Transplantation in Patients without Hemochromatosis
    Papadodima, Stavroula
    Masia, Ricard
    Stone, James R.
    MODERN PATHOLOGY, 2017, 30 : 84A - 84A
  • [27] Liver transplantation in patients with hepatic iron overload: Favorable or unfavorable outcome?
    Keeffe, EB
    HEPATOLOGY, 2000, 32 (06) : 1396 - 1398
  • [28] HFE Gene Mutation, Chronic Liver Disease, and Iron Overload In Turkey
    Oya Yönal
    Özden Hatırnaz
    Filiz Akyüz
    Ugur Özbek
    Kadir Demir
    Sabahattin Kaymakoglu
    Atilla Ökten
    Zeynel Mungan
    Digestive Diseases and Sciences, 2007, 52 : 3298 - 3302
  • [29] HFE gene mutation, chronic liver disease, and iron overload in Turkey
    Yoenal, Oya
    Hatirnaz, Oezden
    Akyuez, Filiz
    Oezbek, Ugur
    Demir, Kadir
    Kaymakoglu, Sabahattin
    Oekten, Atilla
    Mungan, Zeynel
    DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (11) : 3298 - 3302
  • [30] For Better or Worse, Iron Overload by Superparamagnetic Iron Oxide Nanoparticles as a MRI Contrast Agent for Chronic Liver Diseases
    Zhou, Qibing
    Wei, Yushuang
    CHEMICAL RESEARCH IN TOXICOLOGY, 2017, 30 (01) : 73 - 80